Hanchi Xu

Statistics

Publications

Citations

156

H-Index

Active since

2023

Affiliations

Shanghai University of Traditional Chinese Medicine(Current)

Chinese Academy of Medical Sciences & Peking Union Medical College

Second Military Medical University

Chinese Academy of Sciences

Jilin University

Hanchi Xu is an author at Shanghai University of Traditional Chinese Medicine specializing in oncology, programmed death-ligand 1 inhibitors, and medicine.

Publications per year

2023–2025

Publications

Demethylzeylasteral induces PD-L1 ubiquitin–proteasome degradation and promotes antitumor immunity via targeting USP22

Yanyan Zhang, Yun Huang, Dianping Yu et al. · Acta Pharmaceutica Sinica B · 2024 · 32 citations · Full text

Medicine, Oncology, Pharmacology +17

Association between metabolic score for insulin resistance (METS-IR) and hypertension: a cross-sectional study based on NHANES 2007–2018

Zhen Guo, Xia Guo, Hanchi Xu et al. · Lipids in Health and Disease · 2025 · 29 citations · Full text

Public Health, Public Health Nutrition, Epidemiology +16

Acevaltrate as a novel ferroptosis inducer with dual targets of PCBP1/2 and GPX4 in colorectal cancer

Dianping Yu, Hongmei Hu, Qing Zhang et al. · Signal Transduction and Targeted Therapy · 2025 · 29 citations · Full text

Medicine, Oncology, Pharmacology +15

Comprehensive review on gene mutations contributing to dilated cardiomyopathy

Shipeng Wang, Zhiyu Zhang, Jiahuan He et al. · Frontiers in Cardiovascular Medicine · 2023 · 21 citations · Full text

Medicine, Cardiology, Genetics +8

Berberine Derivative B68 Promotes Tumor Immune Clearance by Dual‐Targeting BMI1 for Senescence Induction and CSN5 for PD‐L1 Degradation

Hongmei Hu, Qun Wang, Dianping Yu et al. · Advanced Science · 2024 · 20 citations · Full text

Medicine, Immunology, Oncology +17

1–5 of 7